Systemic Application of Cadonilimab, LM-302, and S-1 Combined With Intraperitoneal Infusion of Paclitaxel for the Treatment of Claudin 18.2-positive Gastric Cancer With Peritoneal Metastasis

NCT06519591 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

40

Enrollment

OTHER

Sponsor class

Conditions

Gastric Cancer Stage IV
Peritoneal Metastases

Interventions

DRUG: Cadonilimab, LM-302, S-1, paclitaxel

Sponsor

Ruijin Hospital